Douglas J. Swirsky - 24 Jun 2022 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)

Role
Director
Signature
/s/ Christina Blakley, attorney-in-fact for Douglas Swirsky
Issuer symbol
CLRB
Transactions as of
24 Jun 2022
Net transactions value
$0
Form type
4
Filing time
01 Aug 2022, 18:01:54 UTC
Previous filing
14 Sep 2021
Next filing
28 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLRB Stock option (right to buy) Award $0 +11,700 $0.000000 11,700 24 Jun 2022 Common Stock 11,700 $4.10 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercise price and quantity have been adjusted for the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022.
F2 This stock option shall vest in full on June 24, 2023, subject to the reporting person's continued service through the applicable vesting date.